Lesion network mapping identifies new brain circuit linked to epilepsy

As­traZeneca said on Mon­day morn­ing it is build­ing a new an­ti­body-drug con­ju­gate fa­cil­i­ty in Sin­ga­pore worth $1.5 bil­lion. The UK phar­ma said this will be

The final rule from HHS on transparency in artificial intelligence (AI) has some positive points, but it won’t solve all the challenges posed by this